Exelixis (EXEL) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q4 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $423.9 million versus the consensus estimate of $416.94 million.
GUIDANCE:
Exelixis sees FY2024 revenue of $1.775-1.875 billion, versus the consensus of $1.84 billion.
2023 Financial Guidance
Exelixis is maintaining the previously provided financial guidance for fiscal year 2023:
Total revenues |
| $1.775 billion - $1.875 billion |
Net product revenues |
| $1.575 billion - $1.675 billion |
Cost of goods sold |
| 4.0% - 5.0% of net product revenues |
Research and development expenses (1) |
| $1,000 million - $1,050 million |
Selling, general and administrative expenses (2) |
| $475 million - $525 million |
Effective tax rate |
| 20% - 22% |
| ____________________ | ||
(1) | Includes $45 million of non-cash stock-based compensation expense. | |
(2) | Includes $55 million of non-cash stock-based compensation expense. | |
| | ||
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
